Insulin Glargine and Lispro Market, Global Outlook and Forecast 2022-2028
As for March, 26 2020:
Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effects of a novel coronavirus on individuals.The scientists involved in the study hope that BCG vaccination may ease the burden on the health system before a specific vaccine for Covid-19 is available.
1.BCG Clinical Trials for Against Covid-19
Researchers in four countries (the Netherlands, Australia, Germany, and the United Kingdom) will soon begin clinical trials of new coronaviruses using unconventional methods.They will test whether a century-old anti-tuberculosis (TB) vaccine (BCG) can broadly improve the body's immune system, making it better able to fight sars-cov-2 and possibly prevent infection altogether.The study will be administered to people at high risk, including physicians and nurses, and to older adults.
A team at the university of Melbourne in Australia is using exactly the same protocol to carry out the BCG study among healthcare workers.Another team at the university of Exeter in the UK will conduct a similar study on older people.Last week, a team at the Max Planck Institute for Infection Biology in Germany announced that, inspired by Netea's work, they would carry out similar clinical trials in older people and healthcare workers with another anti-tb vaccine in development, VPM1002, a genetically modified BCG vaccine.'The elderly and health care workers are bearing the brunt of the current outbreak, so they would particularly benefit if the VPM1002 vaccine could help.'They said.
2.Introduction of BCG
The BCG vaccine consists of an attenuated (weakened) version of a relative of Mycobacterium tuberculosis, the causative agent of TB. The vaccine is in most countries in the world of children after the birth of the first annual vaccination is used, the BCG vaccine to be both safe and cheap, it can prevent an average of about 60% of TB cases, children vary widely between countries.Vaccines typically produce an immune response against the target pathogen, such as antibodies that bind and neutralize one virus but do not bind to others.But BCG may also enhance the immune system's ability to fight pathogens other than tuberculosis, according to decades of published clinical and observational studies.The researchers concluded that in the first year after vaccination, about 30 percent of all known pathogens, including viruses, could be prevented.A 2014 review by the world health organization concluded that BCG appeared to reduce overall child mortality.
3.BCG can 'Train' Innate Immunity
The innate immune system, composed of white blood cells such as macrophages, natural killer cells and neutrophils, should not have this memory.The team, led by professor Netea, found that BCG could survive for months in human skin, stimulating not only the t-cells and b-cells of mycobacterium memoriae, but also the white blood cells responsible for innate immunity, which can quickly respond to new infections.In a randomized placebo-controlled study published in 2018, the team showed that BCG vaccination prevented the yellow fever virus from being experimentally infected.
This report contains market size and forecasts of BCG Vaccine for Prevent Covid-19 in global, including the following market information:
Global BCG Vaccine for Prevent Covid-19 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global BCG Vaccine for Prevent Covid-19 Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five BCG Vaccine for Prevent Covid-19 companies in 2021 (%)
The global BCG Vaccine for Prevent Covid-19 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Dosage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine for Prevent Covid-19 include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, InterVax, Serum Institute of India, GreenSignal, Statens Serum Institute and Shanyao Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCG Vaccine for Prevent Covid-19 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG Vaccine for Prevent Covid-19 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global BCG Vaccine for Prevent Covid-19 Market Segment Percentages, by Type, 2021 (%)
Global BCG Vaccine for Prevent Covid-19 Market Segment Percentages, by Application, 2021 (%)
Global BCG Vaccine for Prevent Covid-19 Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine for Prevent Covid-19 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies BCG Vaccine for Prevent Covid-19 revenues share in global market, 2021 (%)
Key companies BCG Vaccine for Prevent Covid-19 sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies BCG Vaccine for Prevent Covid-19 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effects of a novel coronavirus on individuals.The scientists involved in the study hope that BCG vaccination may ease the burden on the health system before a specific vaccine for Covid-19 is available.
1.BCG Clinical Trials for Against Covid-19
Researchers in four countries (the Netherlands, Australia, Germany, and the United Kingdom) will soon begin clinical trials of new coronaviruses using unconventional methods.They will test whether a century-old anti-tuberculosis (TB) vaccine (BCG) can broadly improve the body's immune system, making it better able to fight sars-cov-2 and possibly prevent infection altogether.The study will be administered to people at high risk, including physicians and nurses, and to older adults.
A team at the university of Melbourne in Australia is using exactly the same protocol to carry out the BCG study among healthcare workers.Another team at the university of Exeter in the UK will conduct a similar study on older people.Last week, a team at the Max Planck Institute for Infection Biology in Germany announced that, inspired by Netea's work, they would carry out similar clinical trials in older people and healthcare workers with another anti-tb vaccine in development, VPM1002, a genetically modified BCG vaccine.'The elderly and health care workers are bearing the brunt of the current outbreak, so they would particularly benefit if the VPM1002 vaccine could help.'They said.
2.Introduction of BCG
The BCG vaccine consists of an attenuated (weakened) version of a relative of Mycobacterium tuberculosis, the causative agent of TB. The vaccine is in most countries in the world of children after the birth of the first annual vaccination is used, the BCG vaccine to be both safe and cheap, it can prevent an average of about 60% of TB cases, children vary widely between countries.Vaccines typically produce an immune response against the target pathogen, such as antibodies that bind and neutralize one virus but do not bind to others.But BCG may also enhance the immune system's ability to fight pathogens other than tuberculosis, according to decades of published clinical and observational studies.The researchers concluded that in the first year after vaccination, about 30 percent of all known pathogens, including viruses, could be prevented.A 2014 review by the world health organization concluded that BCG appeared to reduce overall child mortality.
3.BCG can 'Train' Innate Immunity
The innate immune system, composed of white blood cells such as macrophages, natural killer cells and neutrophils, should not have this memory.The team, led by professor Netea, found that BCG could survive for months in human skin, stimulating not only the t-cells and b-cells of mycobacterium memoriae, but also the white blood cells responsible for innate immunity, which can quickly respond to new infections.In a randomized placebo-controlled study published in 2018, the team showed that BCG vaccination prevented the yellow fever virus from being experimentally infected.
This report contains market size and forecasts of BCG Vaccine for Prevent Covid-19 in global, including the following market information:
Global BCG Vaccine for Prevent Covid-19 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global BCG Vaccine for Prevent Covid-19 Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five BCG Vaccine for Prevent Covid-19 companies in 2021 (%)
The global BCG Vaccine for Prevent Covid-19 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Dosage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine for Prevent Covid-19 include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, InterVax, Serum Institute of India, GreenSignal, Statens Serum Institute and Shanyao Group and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCG Vaccine for Prevent Covid-19 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG Vaccine for Prevent Covid-19 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global BCG Vaccine for Prevent Covid-19 Market Segment Percentages, by Type, 2021 (%)
- by Dosage
- 0.5ml Package
- 1ml Package
- 2ml Package
- Other
- by Type of Inoculator
- Initial Vaccinate
- Revaccination
Global BCG Vaccine for Prevent Covid-19 Market Segment Percentages, by Application, 2021 (%)
- 0-5 Years Old
- 5-18 Years Old
- 18-45 Years Old
- 45-65 Years Old
- ?65 Years Old
Global BCG Vaccine for Prevent Covid-19 Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine for Prevent Covid-19 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies BCG Vaccine for Prevent Covid-19 revenues share in global market, 2021 (%)
Key companies BCG Vaccine for Prevent Covid-19 sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies BCG Vaccine for Prevent Covid-19 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Sanofi Pasteur
- Japan BCG Lab
- China National Biotec
- InterVax
- Serum Institute of India
- GreenSignal
- Statens Serum Institute
- Shanyao Group
- Shanghai Institute of Biological Products
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Insulin Glargine and Lispro Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Glargine and Lispro Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INSULIN GLARGINE AND LISPRO OVERALL MARKET SIZE
2.1 Global Insulin Glargine and Lispro Market Size: 2021 VS 2028
2.2 Global Insulin Glargine and Lispro Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Insulin Glargine and Lispro Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Insulin Glargine and Lispro Players in Global Market
3.2 Top Global Insulin Glargine and Lispro Companies Ranked by Revenue
3.3 Global Insulin Glargine and Lispro Revenue by Companies
3.4 Global Insulin Glargine and Lispro Sales by Companies
3.5 Global Insulin Glargine and Lispro Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Insulin Glargine and Lispro Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Insulin Glargine and Lispro Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Glargine and Lispro Players in Global Market
3.8.1 List of Global Tier 1 Insulin Glargine and Lispro Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Glargine and Lispro Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Insulin Glargine and Lispro Market Size Markets, 2021 & 2028
4.1.2 Branded Drug
4.1.3 Biosimilar Drug
4.2 By Type - Global Insulin Glargine and Lispro Revenue & Forecasts
4.2.1 By Type - Global Insulin Glargine and Lispro Revenue, 2017-2022
4.2.2 By Type - Global Insulin Glargine and Lispro Revenue, 2023-2028
4.2.3 By Type - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
4.3 By Type - Global Insulin Glargine and Lispro Sales & Forecasts
4.3.1 By Type - Global Insulin Glargine and Lispro Sales, 2017-2022
4.3.2 By Type - Global Insulin Glargine and Lispro Sales, 2023-2028
4.3.3 By Type - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
4.4 By Type - Global Insulin Glargine and Lispro Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Insulin Glargine and Lispro Market Size, 2021 & 2028
5.1.2 Type I Dibetes
5.1.3 Type II Dibetes
5.2 By Application - Global Insulin Glargine and Lispro Revenue & Forecasts
5.2.1 By Application - Global Insulin Glargine and Lispro Revenue, 2017-2022
5.2.2 By Application - Global Insulin Glargine and Lispro Revenue, 2023-2028
5.2.3 By Application - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
5.3 By Application - Global Insulin Glargine and Lispro Sales & Forecasts
5.3.1 By Application - Global Insulin Glargine and Lispro Sales, 2017-2022
5.3.2 By Application - Global Insulin Glargine and Lispro Sales, 2023-2028
5.3.3 By Application - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
5.4 By Application - Global Insulin Glargine and Lispro Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Insulin Glargine and Lispro Market Size, 2021 & 2028
6.2 By Region - Global Insulin Glargine and Lispro Revenue & Forecasts
6.2.1 By Region - Global Insulin Glargine and Lispro Revenue, 2017-2022
6.2.2 By Region - Global Insulin Glargine and Lispro Revenue, 2023-2028
6.2.3 By Region - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
6.3 By Region - Global Insulin Glargine and Lispro Sales & Forecasts
6.3.1 By Region - Global Insulin Glargine and Lispro Sales, 2017-2022
6.3.2 By Region - Global Insulin Glargine and Lispro Sales, 2023-2028
6.3.3 By Region - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Insulin Glargine and Lispro Revenue, 2017-2028
6.4.2 By Country - North America Insulin Glargine and Lispro Sales, 2017-2028
6.4.3 US Insulin Glargine and Lispro Market Size, 2017-2028
6.4.4 Canada Insulin Glargine and Lispro Market Size, 2017-2028
6.4.5 Mexico Insulin Glargine and Lispro Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Insulin Glargine and Lispro Revenue, 2017-2028
6.5.2 By Country - Europe Insulin Glargine and Lispro Sales, 2017-2028
6.5.3 Germany Insulin Glargine and Lispro Market Size, 2017-2028
6.5.4 France Insulin Glargine and Lispro Market Size, 2017-2028
6.5.5 U.K. Insulin Glargine and Lispro Market Size, 2017-2028
6.5.6 Italy Insulin Glargine and Lispro Market Size, 2017-2028
6.5.7 Russia Insulin Glargine and Lispro Market Size, 2017-2028
6.5.8 Nordic Countries Insulin Glargine and Lispro Market Size, 2017-2028
6.5.9 Benelux Insulin Glargine and Lispro Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Insulin Glargine and Lispro Revenue, 2017-2028
6.6.2 By Region - Asia Insulin Glargine and Lispro Sales, 2017-2028
6.6.3 China Insulin Glargine and Lispro Market Size, 2017-2028
6.6.4 Japan Insulin Glargine and Lispro Market Size, 2017-2028
6.6.5 South Korea Insulin Glargine and Lispro Market Size, 2017-2028
6.6.6 Southeast Asia Insulin Glargine and Lispro Market Size, 2017-2028
6.6.7 India Insulin Glargine and Lispro Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Insulin Glargine and Lispro Revenue, 2017-2028
6.7.2 By Country - South America Insulin Glargine and Lispro Sales, 2017-2028
6.7.3 Brazil Insulin Glargine and Lispro Market Size, 2017-2028
6.7.4 Argentina Insulin Glargine and Lispro Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin Glargine and Lispro Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Insulin Glargine and Lispro Sales, 2017-2028
6.8.3 Turkey Insulin Glargine and Lispro Market Size, 2017-2028
6.8.4 Israel Insulin Glargine and Lispro Market Size, 2017-2028
6.8.5 Saudi Arabia Insulin Glargine and Lispro Market Size, 2017-2028
6.8.6 UAE Insulin Glargine and Lispro Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi S.A
7.1.1 Sanofi S.A Corporate Summary
7.1.2 Sanofi S.A Business Overview
7.1.3 Sanofi S.A Insulin Glargine and Lispro Major Product Offerings
7.1.4 Sanofi S.A Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi S.A Key News
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporate Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Insulin Glargine and Lispro Major Product Offerings
7.2.4 Eli Lilly and Company Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.2.5 Eli Lilly and Company Key News
7.3 Biocon Limited
7.3.1 Biocon Limited Corporate Summary
7.3.2 Biocon Limited Business Overview
7.3.3 Biocon Limited Insulin Glargine and Lispro Major Product Offerings
7.3.4 Biocon Limited Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.3.5 Biocon Limited Key News
7.4 Cipla Limited
7.4.1 Cipla Limited Corporate Summary
7.4.2 Cipla Limited Business Overview
7.4.3 Cipla Limited Insulin Glargine and Lispro Major Product Offerings
7.4.4 Cipla Limited Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.4.5 Cipla Limited Key News
7.5 Gan & Lee Pharmaceutical Ltd.
7.5.1 Gan & Lee Pharmaceutical Ltd. Corporate Summary
7.5.2 Gan & Lee Pharmaceutical Ltd. Business Overview
7.5.3 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Major Product Offerings
7.5.4 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.5.5 Gan & Lee Pharmaceutical Ltd. Key News
7.6 Julphar Diabetes LLC
7.6.1 Julphar Diabetes LLC Corporate Summary
7.6.2 Julphar Diabetes LLC Business Overview
7.6.3 Julphar Diabetes LLC Insulin Glargine and Lispro Major Product Offerings
7.6.4 Julphar Diabetes LLC Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.6.5 Julphar Diabetes LLC Key News
7.7 Merck & Co.
7.7.1 Merck & Co. Corporate Summary
7.7.2 Merck & Co. Business Overview
7.7.3 Merck & Co. Insulin Glargine and Lispro Major Product Offerings
7.7.4 Merck & Co. Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.7.5 Merck & Co. Key News
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Corporate Summary
7.8.2 Novo Nordisk A/S Business Overview
7.8.3 Novo Nordisk A/S Insulin Glargine and Lispro Major Product Offerings
7.8.4 Novo Nordisk A/S Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.8.5 Novo Nordisk A/S Key News
7.9 SAJA Pharmaceuticals
7.9.1 SAJA Pharmaceuticals Corporate Summary
7.9.2 SAJA Pharmaceuticals Business Overview
7.9.3 SAJA Pharmaceuticals Insulin Glargine and Lispro Major Product Offerings
7.9.4 SAJA Pharmaceuticals Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.9.5 SAJA Pharmaceuticals Key News
7.10 Wockhardt Ltd.
7.10.1 Wockhardt Ltd. Corporate Summary
7.10.2 Wockhardt Ltd. Business Overview
7.10.3 Wockhardt Ltd. Insulin Glargine and Lispro Major Product Offerings
7.10.4 Wockhardt Ltd. Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.10.5 Wockhardt Ltd. Key News
8 GLOBAL INSULIN GLARGINE AND LISPRO PRODUCTION CAPACITY, ANALYSIS
8.1 Global Insulin Glargine and Lispro Production Capacity, 2017-2028
8.2 Insulin Glargine and Lispro Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Glargine and Lispro Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INSULIN GLARGINE AND LISPRO SUPPLY CHAIN ANALYSIS
10.1 Insulin Glargine and Lispro Industry Value Chain
10.2 Insulin Glargine and Lispro Upstream Market
10.3 Insulin Glargine and Lispro Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Glargine and Lispro Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Insulin Glargine and Lispro Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Glargine and Lispro Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INSULIN GLARGINE AND LISPRO OVERALL MARKET SIZE
2.1 Global Insulin Glargine and Lispro Market Size: 2021 VS 2028
2.2 Global Insulin Glargine and Lispro Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Insulin Glargine and Lispro Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Insulin Glargine and Lispro Players in Global Market
3.2 Top Global Insulin Glargine and Lispro Companies Ranked by Revenue
3.3 Global Insulin Glargine and Lispro Revenue by Companies
3.4 Global Insulin Glargine and Lispro Sales by Companies
3.5 Global Insulin Glargine and Lispro Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Insulin Glargine and Lispro Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Insulin Glargine and Lispro Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Glargine and Lispro Players in Global Market
3.8.1 List of Global Tier 1 Insulin Glargine and Lispro Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Glargine and Lispro Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Insulin Glargine and Lispro Market Size Markets, 2021 & 2028
4.1.2 Branded Drug
4.1.3 Biosimilar Drug
4.2 By Type - Global Insulin Glargine and Lispro Revenue & Forecasts
4.2.1 By Type - Global Insulin Glargine and Lispro Revenue, 2017-2022
4.2.2 By Type - Global Insulin Glargine and Lispro Revenue, 2023-2028
4.2.3 By Type - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
4.3 By Type - Global Insulin Glargine and Lispro Sales & Forecasts
4.3.1 By Type - Global Insulin Glargine and Lispro Sales, 2017-2022
4.3.2 By Type - Global Insulin Glargine and Lispro Sales, 2023-2028
4.3.3 By Type - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
4.4 By Type - Global Insulin Glargine and Lispro Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Insulin Glargine and Lispro Market Size, 2021 & 2028
5.1.2 Type I Dibetes
5.1.3 Type II Dibetes
5.2 By Application - Global Insulin Glargine and Lispro Revenue & Forecasts
5.2.1 By Application - Global Insulin Glargine and Lispro Revenue, 2017-2022
5.2.2 By Application - Global Insulin Glargine and Lispro Revenue, 2023-2028
5.2.3 By Application - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
5.3 By Application - Global Insulin Glargine and Lispro Sales & Forecasts
5.3.1 By Application - Global Insulin Glargine and Lispro Sales, 2017-2022
5.3.2 By Application - Global Insulin Glargine and Lispro Sales, 2023-2028
5.3.3 By Application - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
5.4 By Application - Global Insulin Glargine and Lispro Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Insulin Glargine and Lispro Market Size, 2021 & 2028
6.2 By Region - Global Insulin Glargine and Lispro Revenue & Forecasts
6.2.1 By Region - Global Insulin Glargine and Lispro Revenue, 2017-2022
6.2.2 By Region - Global Insulin Glargine and Lispro Revenue, 2023-2028
6.2.3 By Region - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
6.3 By Region - Global Insulin Glargine and Lispro Sales & Forecasts
6.3.1 By Region - Global Insulin Glargine and Lispro Sales, 2017-2022
6.3.2 By Region - Global Insulin Glargine and Lispro Sales, 2023-2028
6.3.3 By Region - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Insulin Glargine and Lispro Revenue, 2017-2028
6.4.2 By Country - North America Insulin Glargine and Lispro Sales, 2017-2028
6.4.3 US Insulin Glargine and Lispro Market Size, 2017-2028
6.4.4 Canada Insulin Glargine and Lispro Market Size, 2017-2028
6.4.5 Mexico Insulin Glargine and Lispro Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Insulin Glargine and Lispro Revenue, 2017-2028
6.5.2 By Country - Europe Insulin Glargine and Lispro Sales, 2017-2028
6.5.3 Germany Insulin Glargine and Lispro Market Size, 2017-2028
6.5.4 France Insulin Glargine and Lispro Market Size, 2017-2028
6.5.5 U.K. Insulin Glargine and Lispro Market Size, 2017-2028
6.5.6 Italy Insulin Glargine and Lispro Market Size, 2017-2028
6.5.7 Russia Insulin Glargine and Lispro Market Size, 2017-2028
6.5.8 Nordic Countries Insulin Glargine and Lispro Market Size, 2017-2028
6.5.9 Benelux Insulin Glargine and Lispro Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Insulin Glargine and Lispro Revenue, 2017-2028
6.6.2 By Region - Asia Insulin Glargine and Lispro Sales, 2017-2028
6.6.3 China Insulin Glargine and Lispro Market Size, 2017-2028
6.6.4 Japan Insulin Glargine and Lispro Market Size, 2017-2028
6.6.5 South Korea Insulin Glargine and Lispro Market Size, 2017-2028
6.6.6 Southeast Asia Insulin Glargine and Lispro Market Size, 2017-2028
6.6.7 India Insulin Glargine and Lispro Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Insulin Glargine and Lispro Revenue, 2017-2028
6.7.2 By Country - South America Insulin Glargine and Lispro Sales, 2017-2028
6.7.3 Brazil Insulin Glargine and Lispro Market Size, 2017-2028
6.7.4 Argentina Insulin Glargine and Lispro Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin Glargine and Lispro Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Insulin Glargine and Lispro Sales, 2017-2028
6.8.3 Turkey Insulin Glargine and Lispro Market Size, 2017-2028
6.8.4 Israel Insulin Glargine and Lispro Market Size, 2017-2028
6.8.5 Saudi Arabia Insulin Glargine and Lispro Market Size, 2017-2028
6.8.6 UAE Insulin Glargine and Lispro Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Sanofi S.A
7.1.1 Sanofi S.A Corporate Summary
7.1.2 Sanofi S.A Business Overview
7.1.3 Sanofi S.A Insulin Glargine and Lispro Major Product Offerings
7.1.4 Sanofi S.A Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi S.A Key News
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporate Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Insulin Glargine and Lispro Major Product Offerings
7.2.4 Eli Lilly and Company Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.2.5 Eli Lilly and Company Key News
7.3 Biocon Limited
7.3.1 Biocon Limited Corporate Summary
7.3.2 Biocon Limited Business Overview
7.3.3 Biocon Limited Insulin Glargine and Lispro Major Product Offerings
7.3.4 Biocon Limited Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.3.5 Biocon Limited Key News
7.4 Cipla Limited
7.4.1 Cipla Limited Corporate Summary
7.4.2 Cipla Limited Business Overview
7.4.3 Cipla Limited Insulin Glargine and Lispro Major Product Offerings
7.4.4 Cipla Limited Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.4.5 Cipla Limited Key News
7.5 Gan & Lee Pharmaceutical Ltd.
7.5.1 Gan & Lee Pharmaceutical Ltd. Corporate Summary
7.5.2 Gan & Lee Pharmaceutical Ltd. Business Overview
7.5.3 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Major Product Offerings
7.5.4 Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.5.5 Gan & Lee Pharmaceutical Ltd. Key News
7.6 Julphar Diabetes LLC
7.6.1 Julphar Diabetes LLC Corporate Summary
7.6.2 Julphar Diabetes LLC Business Overview
7.6.3 Julphar Diabetes LLC Insulin Glargine and Lispro Major Product Offerings
7.6.4 Julphar Diabetes LLC Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.6.5 Julphar Diabetes LLC Key News
7.7 Merck & Co.
7.7.1 Merck & Co. Corporate Summary
7.7.2 Merck & Co. Business Overview
7.7.3 Merck & Co. Insulin Glargine and Lispro Major Product Offerings
7.7.4 Merck & Co. Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.7.5 Merck & Co. Key News
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Corporate Summary
7.8.2 Novo Nordisk A/S Business Overview
7.8.3 Novo Nordisk A/S Insulin Glargine and Lispro Major Product Offerings
7.8.4 Novo Nordisk A/S Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.8.5 Novo Nordisk A/S Key News
7.9 SAJA Pharmaceuticals
7.9.1 SAJA Pharmaceuticals Corporate Summary
7.9.2 SAJA Pharmaceuticals Business Overview
7.9.3 SAJA Pharmaceuticals Insulin Glargine and Lispro Major Product Offerings
7.9.4 SAJA Pharmaceuticals Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.9.5 SAJA Pharmaceuticals Key News
7.10 Wockhardt Ltd.
7.10.1 Wockhardt Ltd. Corporate Summary
7.10.2 Wockhardt Ltd. Business Overview
7.10.3 Wockhardt Ltd. Insulin Glargine and Lispro Major Product Offerings
7.10.4 Wockhardt Ltd. Insulin Glargine and Lispro Sales and Revenue in Global (2017-2022)
7.10.5 Wockhardt Ltd. Key News
8 GLOBAL INSULIN GLARGINE AND LISPRO PRODUCTION CAPACITY, ANALYSIS
8.1 Global Insulin Glargine and Lispro Production Capacity, 2017-2028
8.2 Insulin Glargine and Lispro Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Glargine and Lispro Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INSULIN GLARGINE AND LISPRO SUPPLY CHAIN ANALYSIS
10.1 Insulin Glargine and Lispro Industry Value Chain
10.2 Insulin Glargine and Lispro Upstream Market
10.3 Insulin Glargine and Lispro Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Glargine and Lispro Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Insulin Glargine and Lispro in Global Market
Table 2. Top Insulin Glargine and Lispro Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Insulin Glargine and Lispro Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Insulin Glargine and Lispro Revenue Share by Companies, 2017-2022
Table 5. Global Insulin Glargine and Lispro Sales by Companies, (Liter), 2017-2022
Table 6. Global Insulin Glargine and Lispro Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Insulin Glargine and Lispro Price (2017-2022) & (USD/mL)
Table 8. Global Manufacturers Insulin Glargine and Lispro Product Type
Table 9. List of Global Tier 1 Insulin Glargine and Lispro Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin Glargine and Lispro Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Insulin Glargine and Lispro Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Insulin Glargine and Lispro Sales (Liter), 2017-2022
Table 15. By Type - Global Insulin Glargine and Lispro Sales (Liter), 2023-2028
Table 16. By Application – Global Insulin Glargine and Lispro Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Insulin Glargine and Lispro Sales (Liter), 2017-2022
Table 20. By Application - Global Insulin Glargine and Lispro Sales (Liter), 2023-2028
Table 21. By Region – Global Insulin Glargine and Lispro Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Insulin Glargine and Lispro Sales (Liter), 2017-2022
Table 25. By Region - Global Insulin Glargine and Lispro Sales (Liter), 2023-2028
Table 26. By Country - North America Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 29. By Country - North America Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 30. By Country - Europe Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 33. By Country - Europe Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 34. By Region - Asia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 37. By Region - Asia Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 38. By Country - South America Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 41. By Country - South America Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 42. By Country - Middle East & Africa Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 45. By Country - Middle East & Africa Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 46. Sanofi S.A Corporate Summary
Table 47. Sanofi S.A Insulin Glargine and Lispro Product Offerings
Table 48. Sanofi S.A Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 49. Eli Lilly and Company Corporate Summary
Table 50. Eli Lilly and Company Insulin Glargine and Lispro Product Offerings
Table 51. Eli Lilly and Company Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 52. Biocon Limited Corporate Summary
Table 53. Biocon Limited Insulin Glargine and Lispro Product Offerings
Table 54. Biocon Limited Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 55. Cipla Limited Corporate Summary
Table 56. Cipla Limited Insulin Glargine and Lispro Product Offerings
Table 57. Cipla Limited Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 58. Gan & Lee Pharmaceutical Ltd. Corporate Summary
Table 59. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Product Offerings
Table 60. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 61. Julphar Diabetes LLC Corporate Summary
Table 62. Julphar Diabetes LLC Insulin Glargine and Lispro Product Offerings
Table 63. Julphar Diabetes LLC Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 64. Merck & Co. Corporate Summary
Table 65. Merck & Co. Insulin Glargine and Lispro Product Offerings
Table 66. Merck & Co. Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 67. Novo Nordisk A/S Corporate Summary
Table 68. Novo Nordisk A/S Insulin Glargine and Lispro Product Offerings
Table 69. Novo Nordisk A/S Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 70. SAJA Pharmaceuticals Corporate Summary
Table 71. SAJA Pharmaceuticals Insulin Glargine and Lispro Product Offerings
Table 72. SAJA Pharmaceuticals Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 73. Wockhardt Ltd. Corporate Summary
Table 74. Wockhardt Ltd. Insulin Glargine and Lispro Product Offerings
Table 75. Wockhardt Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 76. Insulin Glargine and Lispro Production Capacity (Liter) of Key Manufacturers in Global Market, 2020-2022 (Liter)
Table 77. Global Insulin Glargine and Lispro Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Insulin Glargine and Lispro Production by Region, 2017-2022 (Liter)
Table 79. Global Insulin Glargine and Lispro Production by Region, 2023-2028 (Liter)
Table 80. Insulin Glargine and Lispro Market Opportunities & Trends in Global Market
Table 81. Insulin Glargine and Lispro Market Drivers in Global Market
Table 82. Insulin Glargine and Lispro Market Restraints in Global Market
Table 83. Insulin Glargine and Lispro Raw Materials
Table 84. Insulin Glargine and Lispro Raw Materials Suppliers in Global Market
Table 85. Typical Insulin Glargine and Lispro Downstream
Table 86. Insulin Glargine and Lispro Downstream Clients in Global Market
Table 87. Insulin Glargine and Lispro Distributors and Sales Agents in Global Market
Table 1. Key Players of Insulin Glargine and Lispro in Global Market
Table 2. Top Insulin Glargine and Lispro Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Insulin Glargine and Lispro Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Insulin Glargine and Lispro Revenue Share by Companies, 2017-2022
Table 5. Global Insulin Glargine and Lispro Sales by Companies, (Liter), 2017-2022
Table 6. Global Insulin Glargine and Lispro Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Insulin Glargine and Lispro Price (2017-2022) & (USD/mL)
Table 8. Global Manufacturers Insulin Glargine and Lispro Product Type
Table 9. List of Global Tier 1 Insulin Glargine and Lispro Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin Glargine and Lispro Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Insulin Glargine and Lispro Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Insulin Glargine and Lispro Sales (Liter), 2017-2022
Table 15. By Type - Global Insulin Glargine and Lispro Sales (Liter), 2023-2028
Table 16. By Application – Global Insulin Glargine and Lispro Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Insulin Glargine and Lispro Sales (Liter), 2017-2022
Table 20. By Application - Global Insulin Glargine and Lispro Sales (Liter), 2023-2028
Table 21. By Region – Global Insulin Glargine and Lispro Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Insulin Glargine and Lispro Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Insulin Glargine and Lispro Sales (Liter), 2017-2022
Table 25. By Region - Global Insulin Glargine and Lispro Sales (Liter), 2023-2028
Table 26. By Country - North America Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 29. By Country - North America Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 30. By Country - Europe Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 33. By Country - Europe Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 34. By Region - Asia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 37. By Region - Asia Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 38. By Country - South America Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 41. By Country - South America Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 42. By Country - Middle East & Africa Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Insulin Glargine and Lispro Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Insulin Glargine and Lispro Sales, (Liter), 2017-2022
Table 45. By Country - Middle East & Africa Insulin Glargine and Lispro Sales, (Liter), 2023-2028
Table 46. Sanofi S.A Corporate Summary
Table 47. Sanofi S.A Insulin Glargine and Lispro Product Offerings
Table 48. Sanofi S.A Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 49. Eli Lilly and Company Corporate Summary
Table 50. Eli Lilly and Company Insulin Glargine and Lispro Product Offerings
Table 51. Eli Lilly and Company Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 52. Biocon Limited Corporate Summary
Table 53. Biocon Limited Insulin Glargine and Lispro Product Offerings
Table 54. Biocon Limited Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 55. Cipla Limited Corporate Summary
Table 56. Cipla Limited Insulin Glargine and Lispro Product Offerings
Table 57. Cipla Limited Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 58. Gan & Lee Pharmaceutical Ltd. Corporate Summary
Table 59. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Product Offerings
Table 60. Gan & Lee Pharmaceutical Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 61. Julphar Diabetes LLC Corporate Summary
Table 62. Julphar Diabetes LLC Insulin Glargine and Lispro Product Offerings
Table 63. Julphar Diabetes LLC Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 64. Merck & Co. Corporate Summary
Table 65. Merck & Co. Insulin Glargine and Lispro Product Offerings
Table 66. Merck & Co. Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 67. Novo Nordisk A/S Corporate Summary
Table 68. Novo Nordisk A/S Insulin Glargine and Lispro Product Offerings
Table 69. Novo Nordisk A/S Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 70. SAJA Pharmaceuticals Corporate Summary
Table 71. SAJA Pharmaceuticals Insulin Glargine and Lispro Product Offerings
Table 72. SAJA Pharmaceuticals Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 73. Wockhardt Ltd. Corporate Summary
Table 74. Wockhardt Ltd. Insulin Glargine and Lispro Product Offerings
Table 75. Wockhardt Ltd. Insulin Glargine and Lispro Sales (Liter), Revenue (US$, Mn) and Average Price (USD/mL) (2017-2022)
Table 76. Insulin Glargine and Lispro Production Capacity (Liter) of Key Manufacturers in Global Market, 2020-2022 (Liter)
Table 77. Global Insulin Glargine and Lispro Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Insulin Glargine and Lispro Production by Region, 2017-2022 (Liter)
Table 79. Global Insulin Glargine and Lispro Production by Region, 2023-2028 (Liter)
Table 80. Insulin Glargine and Lispro Market Opportunities & Trends in Global Market
Table 81. Insulin Glargine and Lispro Market Drivers in Global Market
Table 82. Insulin Glargine and Lispro Market Restraints in Global Market
Table 83. Insulin Glargine and Lispro Raw Materials
Table 84. Insulin Glargine and Lispro Raw Materials Suppliers in Global Market
Table 85. Typical Insulin Glargine and Lispro Downstream
Table 86. Insulin Glargine and Lispro Downstream Clients in Global Market
Table 87. Insulin Glargine and Lispro Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Insulin Glargine and Lispro Segment by Type
Figure 2. Insulin Glargine and Lispro Segment by Application
Figure 3. Global Insulin Glargine and Lispro Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insulin Glargine and Lispro Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insulin Glargine and Lispro Revenue, 2017-2028 (US$, Mn)
Figure 7. Insulin Glargine and Lispro Sales in Global Market: 2017-2028 (Liter)
Figure 8. The Top 3 and 5 Players Market Share by Insulin Glargine and Lispro Revenue in 2021
Figure 9. By Type - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 10. By Type - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 11. By Type - Global Insulin Glargine and Lispro Price (USD/mL), 2017-2028
Figure 12. By Application - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 13. By Application - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 14. By Application - Global Insulin Glargine and Lispro Price (USD/mL), 2017-2028
Figure 15. By Region - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 16. By Region - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 17. By Country - North America Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 18. By Country - North America Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 19. US Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 24. Germany Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 25. France Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 33. China Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 37. India Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 39. By Country - South America Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 40. Brazil Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 44. Turkey Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 48. Global Insulin Glargine and Lispro Production Capacity (Liter), 2017-2028
Figure 49. The Percentage of Production Insulin Glargine and Lispro by Region, 2021 VS 2028
Figure 50. Insulin Glargine and Lispro Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Insulin Glargine and Lispro Segment by Type
Figure 2. Insulin Glargine and Lispro Segment by Application
Figure 3. Global Insulin Glargine and Lispro Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Insulin Glargine and Lispro Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Insulin Glargine and Lispro Revenue, 2017-2028 (US$, Mn)
Figure 7. Insulin Glargine and Lispro Sales in Global Market: 2017-2028 (Liter)
Figure 8. The Top 3 and 5 Players Market Share by Insulin Glargine and Lispro Revenue in 2021
Figure 9. By Type - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 10. By Type - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 11. By Type - Global Insulin Glargine and Lispro Price (USD/mL), 2017-2028
Figure 12. By Application - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 13. By Application - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 14. By Application - Global Insulin Glargine and Lispro Price (USD/mL), 2017-2028
Figure 15. By Region - Global Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 16. By Region - Global Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 17. By Country - North America Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 18. By Country - North America Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 19. US Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 24. Germany Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 25. France Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 33. China Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 37. India Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 39. By Country - South America Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 40. Brazil Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Insulin Glargine and Lispro Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Insulin Glargine and Lispro Sales Market Share, 2017-2028
Figure 44. Turkey Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Insulin Glargine and Lispro Revenue, (US$, Mn), 2017-2028
Figure 48. Global Insulin Glargine and Lispro Production Capacity (Liter), 2017-2028
Figure 49. The Percentage of Production Insulin Glargine and Lispro by Region, 2021 VS 2028
Figure 50. Insulin Glargine and Lispro Industry Value Chain
Figure 51. Marketing Channels
